The shortage problem Ozempic was first approved by the FDA in December 2017 for type 2 diabetes management
AF: Funding acquisition, Investigation, Validation, Writingoriginal draft
The compound semaglutide mimics the bodys own GLP-1 hormone, proving itself a powerful tool in treating Type 2 Diabetes (UCLA Health)
Participants answered the question for four food system groups: farmers, food manufacturers, grocery stores, and restaurants
A full list of who should avoid it and how it interacts with other medicines hasn't been finalised
Graham Lipkin, a Consultant Nephrologist at Queen Elizabeth Hospital Birmingham, highlights this risk: "Some of the side effects of GLP-1 medicines include dehydration, which can result in acute kidney injury (AKI)